The U.S. Centers for Medicare & Medicaid Services said late this afternoon that it will address how it will remedy five years of illegal Medicare Part B underpayments to hospitals for 340B purchased drugs “in future rulemaking,” rather than in its just-released final rule governing Medicare payments in 2023 for hospital outpatient services.
Hospital groups that successfully sued CMS to end the Part B payments cuts are expected to object. They might ask the federal district judge in Washington, D.C., assigned to their lawsuit to order CMS to quickly repay 340B hospitals for improperly withheld payments from 2018 through most of this year. CMS estimates that the cuts currently cost 340B hospitals $1.96 billion a year.
The U.S. Centers for Medicare & Medicaid Services said late this afternoon that it will address how it will remedy five years of illegal Medicare Part B underpayments to hospitals for 340B purchased drugs “in future rulemaking,” rather than in its just-released final rule governing Medicare payments in 2023 for hospital outpatient services.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
